Catheter-based interventions for acute ischaemic stroke currently include clot removal (usually from the medial cerebral artery) with modern stent-retrievers and in one of five patients (who have simultaneous or stand-alone internal carotid occlusion) also extracranial carotid intervention. Several recently published randomized trials clearly demonstrated superiority of catheter-based interventions (with or without bridging thrombolysis) over best medical therapy alone. The healthcare systems should adopt the new strategies for acute stroke treatment (including fast track to interventional lab) to offer the benefits to all suitable acute stroke patients.
Introduction
Acute stroke is one of the leading causes of death worldwide. Over 85% of acute strokes are caused by cerebral ischaemia and ,15% by intracranial bleeding. Among the ischaemic strokes not all are suitable for intervention. Only strokes with a large vessel occlusion ( 30-40% of all strokes) should be considered. Acute regional ischaemia with progressive necrosis is developing quickly during the initial hours after arterial thromboembolic occlusion in acute ischaemic stroke. Restoration of antegrade blood flow in the acutely occluded artery (i.e. reperfusion of the ischaemic tissue) is the most effective therapy. Timely reperfusion halts the progress of necrosis and preserves viable tissue (cerebral penumbra). The pathophysiology of cerebral infarction is different from myocardial infarction. While myocardial infarction is caused by plaque rupture and in situ thrombosis, acute ischaemic stroke is usually caused by embolization from the heart, aorta, or carotid arteries with thromboembolus typically wedged in the medial cerebral artery. There are many similarities, but also many differences between these two potentially fatal diseases. 1 
Evolution of endovascular treatment
The first attempts to treat acute stroke by intravenous thrombolysis were reported in 1976. 2 The first small randomized trial showing potential benefits of thrombolysis when used early in acute stroke was published in 1992 3 and in 1995 the first positive randomized trial of thrombolysis was published. 4 The first official guidelines recommending thrombolysis for acute stroke were published in 2003. 5 Thrombolytic therapy administered within 6 hours after ischaemic stroke onset significantly reduced the proportion of dead or dependent patients (odds ratio, OR, 0.85, 95% CI 0.78 -0.93) at the price of increased risk of symptomatic intracranial haemorrhage (OR 3.75, 95% CI 3.11 -4.51) and early death (OR 1.69, 95% CI 1.44 -1.98). Early death after thrombolysis was mostly attributable to intracranial haemorrhage. Treatment within 3 h of stroke was more effective in reducing death or dependency (OR 0.66, 95% CI 0.56-0.79) without any increase in death. Contemporaneous other antithrombotic drugs increased the risk of death. Participants aged over 80 years benefited equally to those aged under 80 years, particularly if treated within 3 h of stroke. Intra-arterial thrombolysis-despite its use in interventional practice-was never shown to be clinically superior to best medical care 7, 8 and is not approved by FDA.
Direct mechanical reperfusion using catheter-based thrombectomy without thrombolysis was first used in 2001 9 and then emerged in the hands of radiologists and neurosurgeons. The first interventional cardiologist reporting experience with acute stroke intervention was Abelson in 2008. 10 Both reperfusion strategies (thrombolysis and catheter-based intervention) are frequently used together and such therapy is usually called bridging thrombolysis. 11 The complication rates (device fractures, vessel perforations, new territory embolization, etc.) with the old-generation coil-retrievers were high (7-19%) and the revascularization rates achieved were only moderate.
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The improved technology (specifically the introduction of modern stent-retrievers) significantly improved the results of catheter-based interventions for acute stroke. 15, 16 The latest published official guidelines 17 did not yet recognize direct mechanical intervention as the accepted routine therapy for acute stroke. However, this is currently changing: while novel guidelines are being prepared, the European Stroke Organization issued a press release 'Mechanical thrombectomy improves outcomes in acute ischaemic stroke' (http://www. eso-stroke.org/eso-stroke/strokeinformation/press-releases/20-february-2015.html).
Why trials published before 2014 failed to demonstrate the benefit from interventions?
The first three major randomized trials comparing endovascular treatment of acute stroke vs. intravenous thrombolysis were published in March 2013. 18 -20 Their results were disappointing due to several important limitations: low (1 -13% in different trials) use of stent-retrievers, the absence of treatable arterial occlusion (no pre-intervention vascular imaging) in a significant proportion of patients, long time delays, low number of patients treated per centre per year, etc. (Table 1) .
2015:
The year of change. Why recent trials provided clear evidence favouring interventional treatment?
The recent trials using new-generation stent-retrievers, preprocedural vascular imaging, and implementing much better design and logistics leading to shortening of time delays 21 -25 have demonstrated very clear benefit of catheter-based interventions. Most of these trials used intravenous thrombolysis (whenever indicated) in both study arms and enrolled also thrombolysis ineligible patients, confirming thus superiority of catheter-based interventions + optimal medical therapy over optimal medical therapy alone which might included thrombolysis whenever indicated ( Table 2) .
Current techniques for intracranial and carotid interventions
The following terminology is used in this manuscript: catheter-based interventions (all types of mechanical interventions for acute stroke), catheter-based thrombectomy (specific procedure for clot removal using stent-retrievers and/or aspiration catheters), balloon dilatation, and carotid artery stenting. The current techniques of catheter-based intervention for acute stroke use guiding catheters (frequently with distal-tip balloons for proximal protection during thrombus retrieval), microcatheters with 0.010 ′′ or 0.014 ′′ guidewires (for selective cannulation of the occluded artery), distal aspiration (distal access) catheters with extremely soft tip (for direct thrombus aspiration), stent-retrievers (for immediate flow restoration and thrombus retrieval), small-size dilatation balloons (for rather rare intracranial stenosis dilatation), carotid dilatation balloons (for internal carotid dilatation-some operators prefer this approach in the acute phase of stroke rather than acute carotid stenting), distal protection devices (during carotid interventions-however, its role in acute stroke setting is not well established), carotid stents (some operators prefer acute carotid stenting over balloon dilatation alone when stroke is caused by extracranial carotid occlusion), coronary stents (in very rare situations of extracranial lesions-e.g. vertebral artery stenosis). Intracranial stenting should be avoided whenever possible. Examples of angiographic findings during acute stroke interventions are in Figures 1 -3 .
The role of imaging in selection of patients for intervention
Recanalization of an occluded artery in acute ischaemic stroke may save patient life and return his/her neurologic functions (when performed early in the course of stroke), but it can also led to intracranial bleeding, progression of neurologic dysfunction and death (when performed too late). The critical period for clinically meaningful and safe recanalization varies from 2 to 3 h in patients with limited collateral flow to .8 h (and in rare cases usually in young patients even over 24 h) in patients with better collaterals. The most important variable is the ratio between penumbra (reversible ischaemia) and ischaemic core (irreversible ischaemia). The size of penumbra is determined by collateral flow and the status of capillaries, 26 by localization and completeness of arterial occlusion and other variables. It is of utmost importance to know the ratio penumbra/ischaemic core prior to the reperfusion treatment (thrombolysis, catheter-based mechanical intervention, or both combined). The possible approaches vary from relatively simple Alberta Stroke Program Early CT score (ASPECTS) to sophisticated methods of quantitative perfusion CT imaging or magnetic resonance diffusion weighted imaging (MRI DWI). The details of these methods are beyond the scope of this article. The key principles are: (i) CT imaging should be followed by intervention as soon as possible, otherwise its conclusion may not be valid anymore at the time of delayed intervention (the ischaemic core may become larger and penumbra smaller during the interval between CT and intervention), (ii) Penumbra imaging is less important in very early presenters (e.g. symptom onset-CT time ,2 h) due to the fact that significant penumbra is present in most of them and every minute of time delay (due to sophisticated imaging or interpretation of its results) is extremely critical in these patients (in other words: quick simple CT scan can be sufficient in very early presenters), and (iii) penumbra imaging is critically important in late presenters-it may indicate the intervention in some (usually younger) patients in whom the long (e.g. .6 h) time delay from symptom onset would otherwise lead to conservative therapy ( Figure 4 ). However, penumbra imaging has definite limitations: inherent time delay (performing and interpreting perfusion imaging delays the intervention by 30 min), difficulties in clear-cut separation between penumbra and ischaemic core, difficulties to distinguish true penumbra from benign oligaemia, etc.
The importance of time
The role of time delay from stroke onset to recanalization is even more critical in acute stroke than in acute myocardial infarction. On the other hand, the rate of necrosis progression in acute stroke is more variable due to variability of collateral flow. One extreme may be a young patient with very good collaterals, who could recover after thrombectomy performed even after 24 h from stroke onset, while the other extreme may be an elderly patient with limited reserve, in whom an angiographically successful thrombectomy done within 2 h after symptom onset may be futile (no neurologic recovery). Nevertheless, the positive results were obtained in the five trials with short onset to recanalization times (median times ,6 h). Studies showing the best outcomes were those with the shorter onset recanalization times.
There are several ways how to minimize the delays related to healthcare system: 'double alert system' (preliminary cath-lab alert immediately when a potential stroke patient is on his way to the hospital, followed by a confirmatory cath-lab alert after neurologic examination and brain imaging), bypassing emergency room (direct emergency medical service (EMS) transfer to CT suite in patients with high clinical suspicion for stroke), avoiding sophisticated imaging (CT perfusion or MRI) in early presenters with suitable CT scan or CT angiogram, bypassing intensive care unit (direct transfer from CT suite to cath-lab), short distance from CT to cath-lab. Future technologic improvements could help-e.g. mobile stroke units, rotational flat panel CT angiograms, etc.
However, most delays are patient related. Thus, ongoing public information campaigns about acute stroke symptoms and importance of time are critically important, too. Acute stroke interventions
Logistics and workflow
Acute ischaemic stroke should be treated as super-emergency, i.e. similar or even faster than acute myocardial infarction or acute traumatic external bleeding. The suggested optimal logistics and sequence of steps is described in Figure 5 .
Unresolved questions
The recently published trials and the widespread enthusiasm in favour of acute stroke interventions open many questions, which still wait to be answered:
(1) What is the optimal periprocedural antithrombotic medication? How small dose of antithrombotics is safe to prevent catheter clotting and how big dose of antithrombotics is safe to prevent intracranial bleeding? 27 Possible algorithm for periprocedural antithrombotic therapy is suggested in Table 3 . (2) What is the role of thrombolysis in patients who can proceed to angio suite immediately after CT imaging and intervention can start within 30 -45 min after CT? Direct catheter-based intervention (without thrombolysis) is used more and more in this situation in many centres despite it is not included in the guidelines. Is such approach right or wrong? (3) The role of long distance transport: can acute stroke patients transferred for long distances to comprehensive stroke centres derive a real benefit? 28 (4) Is intubation and general anaesthesia harmful for acute stroke patients and should most interventions be done without general anaesthesia?
29 (5) What is the role of carotid stenting in acute phase of ischaemic stroke? 30 How should tandem [internal carotid artery Figure 4 Possible role of penumbra imaging in the decision-making process (for details see the text). This is a suggested possibility, which should be further explored. This figure applies only to ,30% of acute stroke patients, in whom intervention might be considered. In majority of strokes, intervention is not indicated due to a different stroke cause (haemorrhagic stroke, lacunar stroke, etc.). 
Deferred stent implantation
Periprocedural heparin 25-40 U/kg Aspirin 200-300 mg just prior to stent implantation, followed by 100 mg/day Clopidogrel 75 mg/day starting just after stenting Periprocedural heparin 25-40 U/kg Aspirin 200-300 mg just prior to stent implantation, followed by 100 mg/day Clopidogrel 75 mg/day starting just after stenting Acute stroke interventions may destroy the initial benefit gained by reperfusion. Some centres are moving towards 'deferred stenting strategy': acute ICA occlusion (or critical stenosis) in the acute phase of stroke is treated only by balloon dilatation to allow restoration of flow and access to any possible intracranial emboli in MCA and stent is implanted few days later when bleeding is absent and clopidogrel can be allowed before stenting. Suggested algorithm for interventions is in Table 4 . (6) What is better for the patients: fast track to angio suite with simple imaging (CT/computed tomographic angiography) or sophisticated penumbra imaging (MRI or perfusion CT) with inherent delay?
Implications for healthcare systems
The published data suggest that the healthcare systems have to implement acute stroke interventions as integral part of care for patients with this deadly disease. 17,31 -33 In principle, there are two ways how to build the system: (i) Highly selective centralized system (comprehensive stroke centres for regions with .1 million citizens or more) including sophisticated penumbra imaging to select patients with the highest likelihood for clinical success of catheterbased interventions or (ii) less selective and partly decentralized system (stroke centres for regions with 0.3 -0.5 million citizenssimilar density to primary PCI centres for STEMI) with more simple pre-procedural imaging, but with potential to decrease the total ischaemic times by 1 h or even more (no transport to distant comprehensive stroke centre, no sophisticated imaging). The first option will result in significantly fewer patients treated with significantly better results. The second option will offer this treatment to almost all acute stroke patients at the price of less excellent results. Another important question is which specialists should perform interventions. The involved specializations include mostly interventional radiologists, but in some areas other specialists are involved: neurosurgeons in the USA, interventional angiologists in Germany and Switzerland, sometimes vascular surgeons, and rarely interventional neurologists or interventional cardiologists. The formal specialization is not important. The involved physicians performing acute stroke interventions should fulfil certain basic requirements: knowledge of acute stroke pathophysiology and of neurovascular anatomy, knowledge of specific problems related to antithrombotic drugs during acute stroke, regular practice in invasive catheter procedures other than just acute strokes, experience with carotid stenting, and of course training in specific acute stroke interventional techniques.
The role of vascular neurologists and the stroke units following the procedures remains an important integral part of patient care, but is beyond the scope of this review article.
Thus, acute stroke interventional treatment is a fascinating, quickly developing field with new publications occurring almost every week. A comprehensive review 34 and a recent meta-analysis 35 
